What is ZBH's five-year median P/E?

25.6x. Half of ZBH's weekly readings since March 2022 were higher and half were lower. This page has 243 weekly readings, from Mar 7, 2022 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares ZBH only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Zimmer Biomet (ZBH) valuation history

Health Care

$97.47

Latest weekly close · Market cap $18.8B

Within its usual range

Zimmer Biomet's P/E of 23.7x is lower than 66% of its weekly readings since March 2022 (as of Oct 30, 2026).

Forward P/E 10.9× (analyst estimates, not ranked).

Weekly P/E since March 2022

P/E each weekMiddle half of its readingsMedian 25.6×

Median: 25.6×
Low to high: 19.2× to 125.9×
Versus median: -8%
History starts: March 2022

P/E

34thpercentile

of its weekly readings since March 2022

Growth, last 12 months vs the year before

Revenue: +9%accelerating
EPS: 0%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

ZBH P/E at each year-end
Year-end	P/E	5-year percentile
Dec 29, 2025	22.3×	21
Dec 30, 2024	19.9×	0
Dec 25, 2023	53.9×	23
Dec 26, 2022	96.6×	41

Health Care peers on P/E

Each percentile compares a stock with its own last five years.

Compare ZBH with peers

Health Care peers of ZBH on P/E
Stock	P/E	Versus its own history	5-year percentile
ABTAbbott Laboratories	33.7×	Above its usual range	73
BAXBaxter International	n/m	Not ranked	n/m, not ranked
BSXBoston Scientific	17.3×	Historically low	1
DXCMDexcom	31.5×	Historically low	7
EWEdwards Lifesciences	54.3×	Historically high	99

Appears in

Sector: Health Care
Screens: Stocks Below Their 5-Year Median P/E
Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on ZBH

No articles about ZBH yet. How valuation percentiles work

Loading peers and related research…

About this history

What is ZBH's current P/E?: Zimmer Biomet's P/E of 23.7x is lower than 66% of its weekly readings since March 2022 (as of Oct 30, 2026).
What is ZBH's five-year median P/E?: 25.6x. Half of ZBH's weekly readings since March 2022 were higher and half were lower. This page has 243 weekly readings, from Mar 7, 2022 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares ZBH only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.